GLP-1 & incretin medicines

Wegovy (injection)

semaglutide · GLP-1 receptor agonist · Novo Nordisk

✓Last reviewed · Written by Dr. George Grunberger · Medical review: pending — clinician review in progress · How we review

In short

Wegovy (semaglutide) is a GLP-1 receptor agonist made by Novo Nordisk, used for weight reduction and long-term maintenance in adults and children 12+ with obesity, or adults with overweight and a weight-related condition, reduce major cardiovascular events in adults with heart disease and obesity or overweight and MASH (fatty liver disease) with moderate-to-advanced fibrosis in adults. Schedule: once weekly. It is prescription-only in the US and Canada.

FormSingle-dose prefilled pen, subcutaneous injection
How oftenOnce weekly
United StatesFDA-approved. A higher 7.2 mg dose, Wegovy HD, was approved March 19, 2026.
CanadaApproved in Canada. Health Canada authorized the first generic semaglutide for weight management on June 29, 2026.
PrescriptionRequired
⚠ Boxed warning: risk of thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What it is used for

  • Weight reduction and long-term maintenance in adults and children 12+ with obesity, or adults with overweight and a weight-related condition
  • Reduce major cardiovascular events in adults with heart disease and obesity or overweight
  • MASH (fatty liver disease) with moderate-to-advanced fibrosis in adults

Wegovy dosage

Per the official label. Your prescriber sets your dose — never change it on your own.

Wegovy label dosing schedule
1Weeks 1–40.25 mg weekly
2Weeks 5–80.5 mg weekly
3Weeks 9–121 mg weekly
4Weeks 13–161.7 mg weekly
5Week 17 on2.4 mg weekly (or 1.7 mg if 2.4 mg is not tolerated)
6Wegovy HD7.2 mg weekly for adults who have tolerated 2.4 mg for at least 4 weeks
Wegovy dose stepsWeeks 1–4: 0.25 mg; Weeks 5–8: 0.5 mg; Weeks 9–12: 1 mg; Weeks 13–16: 1.7 mg; Week 17 on: 2.4 mg; Wegovy HD: 7.2 mg0.25 mgWeeks 1–40.5 mgWeeks 5–81 mgWeeks 9–121.7 mgWeeks 13–162.4 mgWeek 17 on7.2 mgWegovy HD
Wegovy label titration, step by step. Doses go up only as tolerated and as your prescriber decides.

How to take it

Inject under the skin of the stomach, thigh or upper arm on the same day each week.

Storage

Refrigerate 36–46°F (2–8°C). May be kept at up to 86°F (30°C) for up to 28 days. Do not freeze.

Side effects

Common

  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal pain
  • Indigestion / heartburn
  • Fatigue
  • Decreased appetite

Serious — get medical help

  • Pancreatitis (severe stomach pain that may spread to the back)
  • Gallbladder problems, including gallstones
  • Low blood sugar when combined with insulin or a sulfonylurea
  • Kidney problems, often from dehydration after vomiting or diarrhea
  • Serious allergic reactions
  • Diabetic retinopathy complications (people with type 2 diabetes)
  • Pulmonary aspiration during anesthesia or deep sedation — tell your surgical team you take it

Who should not use it

  • Personal or family history of medullary thyroid carcinoma, or MEN 2
  • Prior serious allergic reaction to the drug or its ingredients
  • Pregnancy (stop before a planned pregnancy as advised by your prescriber)
  • Use together with another GLP-1 receptor agonist

Cost

US self-pay through NovoCare and partners has been about $349/month for 0.25–2.4 mg, with intro offers on starter doses; Wegovy HD self-pay was listed around $399/month. Verify before filling.

GLP-1 cost without insurance →

How to buy Wegovy legally

  1. Get a prescription from your doctor or a licensed telehealth provider.
  2. Fill it at a licensed pharmacy, or through the manufacturer's self-pay pharmacy.
  3. Verify any online pharmacy first (US: safe.pharmacy; Canada: your provincial pharmacy college register).

Buying legally in the USA → Buying legally in Canada →

Common questions

Frequently asked questions

Wegovy vs Ozempic: what's the difference?

Same molecule, different approvals and doses. Wegovy is for weight management (up to 2.4 mg, or 7.2 mg as Wegovy HD); Ozempic is for type 2 diabetes (up to 2 mg).

What is Wegovy HD?

A 7.2 mg weekly dose approved in March 2026. In the STEP UP trial it produced about 21% average weight loss versus about 18% for 2.4 mg. Altered skin sensation was more common at the higher dose.

Do I have to stay on Wegovy?

Studies show weight often returns after stopping. Long-term plans should be agreed with your prescriber.

Also searched as: Wegovy pen, Wegovy shot, Wegovy injection, Wegovy HD, Wegovy 7.2 mg, Wegovy 2.4 mg, Wegovey, Wegovi, Wegovy semaglutide, semaglutide for weight loss, weight loss injection, weight loss shot, Wegovy price, Wegovy cost, buy Wegovy, Wegovy NovoCare

Sources

Checked against these primary sources on .

Contact
Esc

↑↓ navigate↵ open